Colon Cancer
New colon cancer data have been reported by researchers at Turku University
Published in Clinical Oncology Week, April 27th, 2009
"However, it is well established that a subgroup of patients with stage II are at high risk for recurrence within their lifetime and should be considered for adjuvant chemotherapy. The present work was designed to study the prognostic value of nuclear DNA content in stage H CRC of patients with long-term follow-up. Isolated nuclei from 50 mu m-thick paraffin sections of tissue samples from 253 patients with stage II CRC, who had undergone bowel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Academy of Sleep Medicine
Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients - American Cancer Society
Racial disparities persist in the treatment of lung cancer - American Cancer Society
Study of neighborhoods points to modifiable factors, not race, in cancer disparities - American Friends of Tel Aviv University
A 'bionic nose' that knows - American Society for Nutrition
Low glycemic breakfast may increase benefits of working out - Biotechnology and Biological Sciences Research Council
Biological FM signal maintains inflammation in cancer, asthma and other diseases - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
